DRP Cancer Tests

ALLARITY MEDICAL LABORATORY

Available DRP Cancer Tests

Over the years, Allarity Medical Laboratory has developed a comprehensive range of Drug Response Predictors (DRPs) that can be applied by other organizations for investigational or research use.

These tools provide valuable insights into the effectiveness of specific drugs based on the gene expression signatures of patients’ tumors, and may aid the development of personalized medicine and targeted therapies.

Advanced Predictive Cancer Testing using DRP

The Drug Response Predictor (DRP®) is a proprietary diagnostic platform that analyzes transcriptional (RNA) changes in tumor cells in response to various drug types. It leverages gene expression data from over 3,000 patient tumors and millions of datapoints to identify patient responders and studied in more than 35 clinical trials across numerous cancer indications and drug types. Read more about the DRP here.

Available DRP Cancer Tests

Cancer Types Covered

Allarity has made research use only (RUO) drug response predictors (DRP) for the following 16 cancer types:

  • Breast
  • Ovarian
  • RCC (Renal Cell Carcinoma)
  • Prostate
  • Endometrial
  • NSCLC (Non-Small Cell Lung Cancer)
  • HCC (Hepatocellular Carcinoma)
  • Colon
  • Glioma
  • Esophagus
  • MDS (Myelodysplastic Syndromes)
  • AML (Acute Myeloid Leukemia)
  • ALL (Acute Lymphoblastic Leukemia)
  • CLL (Chronic Lymphocytic Leukemia)
  • Myeloma
  • DLBCL (Diffuse Large B-Cell Lymphoma)
Drugs Analyzed

In parallel, Allarity has developed RUO drug response predictors for the following drugs:

# Drug Regulatory Status Scientific Publications*
1 Afatinib RUO
2 Alectinib RUO
3 Anastrozole RUO
4 Ara-C RUO
5 Arsenic trioxide RUO
6 Asparaginase RUO
7 AS605240 RUO
8 Axitinib RUO
9 AZD6482 RUO
10 AZD8055 RUO
11 Belinostat RUO Link to publication
12 Bendamustine RUO
13 Bleomycin RUO
14 Bortezomib RUO Link to publication
15 Bosutinib RUO
16 Busulfan RUO
17 Cabozantinib RUO
18 Carfilzomib RUO
19 Carmustine RUO
20 Capecitabine RUO
21 Cetuximab RUO
22 Clofarabine RUO
23 Cobimetinib RUO
24 CP466722 RUO
25 Crizotinib RUO
26 CUDC-101 RUO
27 Cyclophosphamide RUO
28 CX-5461 RUO
29 Dacarbazine RUO
30 Dabrafenib RUO
31 Dasatinib RUO
32 Daunorubicin RUO
33 Decitabine RUO
34 Depsipeptide RUO
35 Dexamethasone RUO
36 Docetaxel RUO
37 Dovitinib IUO Link to publication
38 Doxorubicin RUO Link to publication
39 Epirubicin RUO Link to publication
40 Eribulin RUO
41 Erlotinib RUO
42 Estramustine RUO
43 Etoposide RUO
44 Everolimus RUO
45 Exemestane RUO
46 Fedratinib RUO
47 Fludarabine RUO
48 Fulvestrant RUO Link to publication
49 Gemcitabine RUO
50 Hydroxyurea RUO
51 Ibrutinib RUO
52 Idarubicin RUO
53 Idelalisib RUO
54 Imatinib RUO
55 Iressa RUO
56 Irinotecan RUO
57 Irofulven RUO
58 Ixazomib RUO
59 Ixabepilone IUO
60 KU-55933 RUO
61 Lapatinib RUO
62 Lenalidomide RUO
63 Lenvatinib RUO
64 Lestaurtinib RUO
65 Leukeran RUO
66 Linifanib RUO
67 Lomustine RUO
68 Mechlorethamine RUO
69 Melphalan RUO Link to publication
70 Mercaptopurine RUO
71 Methotrexate RUO
72 Midostaurin RUO
73 Mitoxantrone RUO
74 Navitoclax RUO
75 Nilotinib RUO
76 Olaparib RUO
77 OSI-027 RUO
78 Oxaliplatin RUO
79 Paclitaxel RUO
80 Palbociclib RUO
81 Panobinostat RUO
82 Pazopanib RUO
83 Perifosine RUO
84 Pralatrexate RUO
85 Procarbazine RUO
86 Quizartinib RUO
87 Rapamycin RUO
88 Rucaparib RUO
89 Ruxolitinib RUO
90 Seliciclib RUO
91 Selumetinib RUO
92 Sepantronium RUO
93 Sorafenib RUO
94 TAE-684 RUO
95 Tamoxifen RUO
96 Tanespimycin RUO
97 Tarceva RUO
98 Temsirolimus RUO
99 Teniposide RUO
100 Thalidomide RUO
101 Thioguanine RUO
102 Thiotepa RUO
103 Tivozanib RUO
104 Trametinib RUO
105 Valrubicin RUO
106 Veliparib RUO
107 Vemurafenib RUO
108 Venetoclax RUO
109 Vinblastine RUO
110 Vincristine RUO
111 Vinorelbine RUO Link to publication
112 Vorinostat RUO
113 YK-4-279 RUO
114 QL-X-138 RUO
115 5-Fluorouracil RUO Link to publication
# Drug Regulatory Status Scientific Publications*
1 Afatinib RUO
2 Alectinib RUO
3 Anastrozole RUO
4 Ara-C RUO
5 Arsenic trioxide RUO
6 Asparaginase RUO
7 AS605240 RUO
8 Axitinib RUO
9 AZD6482 RUO
10 AZD8055 RUO
11 Belinostat RUO Link to publication
12 Bendamustine RUO
13 Bleomycin RUO
14 Bortezomib RUO Link to publication
15 Bosutinib RUO
16 Busulfan RUO
17 Cabozantinib RUO
18 Carfilzomib RUO
19 Carmustine RUO
20 Clofarabine RUO
21 Cobimetinib RUO
22 CP466722 RUO
23 Crizotinib RUO
24 CUDC-101 RUO
25 CX-5461 RUO
26 Dacarbazine RUO
27 Dabrafenib RUO
28 Dasatinib RUO
29 Daunorubicin RUO
30 Decitabine RUO
31 Depsipeptide RUO
32 Docetaxel RUO
33 Dovitinib IUO Link to publication
34 Doxorubicin RUO Link to publication
35 Epirubicin RUO Link to publication
36 Eribulin RUO
37 Erlotinib RUO
38 Estramustine RUO
39 Everolimus RUO
40 Exemestane RUO
41 Fedratinib RUO
42 Fludarabine RUO
43 Fulvestrant RUO Link to publication
44 Gemcitabine RUO
45 Hydroxyurea RUO
46 Ibrutinib RUO
47 Idarubicin RUO
48 Idelalisib RUO
49 Imatinib RUO
50 Iressa RUO
51 Irinotecan RUO Link to publication
52 Irofulven RUO
53 Ixazomib RUO
54 Ixabepilone IUO
55 KU-55933 RUO
56 Lapatinib RUO
57 Lenalidomide RUO
58 Lenvatinib RUO
59 Lestaurtinib RUO
60 Leukeran RUO
61 Linifanib RUO
62 Lomustine RUO
63 Mechlorethamine RUO
64 Melphalan RUO Link to publication
65 Mercaptopurine RUO
66 Methotrexate RUO
67 Midostaurin RUO
68 Mitoxantrone RUO
69 Navitoclax RUO
70 Nilotinib RUO
71 Olaparib RUO